Stryker (SYK) Stock Forecast, Price Target & Predictions

OverviewRevenue Ownership Financials Chart Transcripts

SYK Stock Forecast

Stryker stock forecast is as follows: an average price target of $317.96 (represents a -17.56% downside from SYK’s last price of $385.68) and a rating consensus of 'Buy', based on 18 wall street analysts offering a 1-year stock forecast.

SYK Price Target

The average price target for Stryker (SYK) is $317.96 based on 1-year price targets from 18 Wall Street analysts in the past 3 months, with a price target range of $420.00 to $245.00. This represents a potential -17.56% downside from SYK's last price of $385.68.

SYK Analyst Ratings

Buy

According to 18 Wall Street analysts, Stryker's rating consensus is 'Buy'. The analyst rating breakdown for SYK stock is 0 'Strong Buy' (0.00%), 15 'Buy' (83.33%), 3 'Hold' (16.67%), 0 'Sell' (0.00%), and 0 'Strong Sell' (0.00%).

Stryker Price Target by Analyst

Date	Analyst	Company	Price Target	Price when Published	Price Target/Price when Published	Price Target/Last Closing Price
Oct 31, 2024	Joanne Wuensch	Citigroup	$411.00	$363.43	13.09%	6.57%
Oct 30, 2024	Matt O'Brien	Piper Sandler	$420.00	$367.95	14.15%	8.90%
Oct 30, 2024	Richard Newitter	Truist Financial	$380.00	$365.42	3.99%	-1.47%
Oct 30, 2024	Kyle Rose	Canaccord Genuity	$400.00	$359.01	11.42%	3.71%
Oct 30, 2024	Ryan Zimmerman	BTIG	$394.00	$359.01	9.75%	2.16%
Oct 14, 2024	Richard Newitter	Truist Financial	$370.00	$356.45	3.80%	-4.07%
Sep 10, 2024	Matt O\'Brien	Piper Sandler	$380.00	$365.22	4.05%	-1.47%
Aug 28, 2024	Ryan Zimmerman	BTIG	$374.00	$358.51	4.32%	-3.03%
Aug 01, 2024	Richard Newitter	Truist Financial	$345.00	$327.00	5.50%	-10.55%
Jul 31, 2024	Ryan Zimmerman	BTIG	$360.00	$330.22	9.02%	-6.66%

Row per page

Go to

The latest Stryker stock forecast, released on Oct 31, 2024 by Joanne Wuensch from Citigroup, set a price target of $411.00, which represents a 13.09% increase from the stock price at the time of the forecast ($363.43), and a 6.57% increase from SYK last price ($385.68).

Stryker Price Target by Period

	1M	3M	12M
# Anlaysts	5	8	14
Avg Price Target	$401.00	$391.13	$381.71
Last Closing Price	$385.68	$385.68	$385.68
Upside/Downside	3.97%	1.41%	-1.03%

In the current month, the average price target of Stryker stock is $401.00, according to 5 Wall Street analysts offering twelve months forecast. The average price target represents a 3.97% increase as opposed to Stryker's last price of $385.68. This month's average price target is up 2.52% compared to last quarter, and up 5.05% compared to last year.

Analyst Ratings Upgrades/Downgrades

Date	Company	Previous Rating	New Rating	Rating Change
Oct 31, 2024	Barclays	Overweight	Overweight	Hold
Oct 31, 2024	Citigroup	Buy	Buy	Hold
Oct 30, 2024	Piper Sandler	Overweight	Overweight	Hold
Oct 30, 2024	UBS	Neutral	Neutral	Hold
Oct 30, 2024	Canaccord Genuity	Buy	Buy	Hold
Oct 14, 2024	Wolfe Research	Buy	Buy	Hold
Oct 14, 2024	BTIG	Buy	Buy	Hold
Oct 01, 2024	Evercore ISI	Outperform	Outperform	Hold
Sep 10, 2024	Piper Sandler	Overweight	Overweight	Hold
Sep 09, 2024	Wolfe Research	-	Outperform	Initialise

Row per page

Go to

Stryker's last stock rating was published by Barclays on Oct 31, 2024. The company gave SYK a "Overweight" rating, the same as its previous rate.

Stryker Financial Forecast

Stryker Revenue Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Revenue	-	-	-	-	-	-	-	-	-	-	-	-	$5.82B	$4.91B	$5.00B	$4.78B	$5.20B	$4.48B	$4.49B	$4.28B	$4.70B	$4.16B	$4.29B	$3.95B	$4.26B	$3.74B	$2.76B	$3.59B	$4.13B	$3.59B
Avg Forecast	$7.42B	$6.42B	$6.35B	$6.14B	$6.86B	$5.95B	$5.89B	$5.70B	$6.36B	$5.37B	$5.40B	$5.10B	$5.60B	$4.87B	$4.83B	$4.57B	$4.96B	$4.47B	$4.53B	$4.18B	$4.65B	$4.22B	$4.14B	$3.95B	$4.33B	$3.41B	$2.59B	$3.57B	$4.11B	$3.58B
High Forecast	$7.55B	$6.53B	$6.46B	$6.25B	$6.99B	$6.05B	$6.00B	$5.79B	$6.49B	$5.37B	$5.40B	$5.10B	$5.70B	$4.91B	$4.91B	$4.65B	$5.05B	$4.47B	$4.53B	$4.18B	$4.65B	$4.22B	$4.14B	$3.95B	$4.33B	$3.41B	$2.59B	$3.57B	$4.11B	$3.58B
Low Forecast	$7.27B	$6.30B	$6.22B	$6.02B	$6.73B	$5.83B	$5.78B	$5.53B	$6.27B	$5.37B	$5.40B	$5.10B	$5.49B	$4.81B	$4.73B	$4.48B	$4.87B	$4.47B	$4.53B	$4.18B	$4.65B	$4.22B	$4.14B	$3.95B	$4.33B	$3.41B	$2.59B	$3.57B	$4.11B	$3.58B
# Analysts	6	4	4	6	4	3	7	9	17	15	8	9	13	16	8	9	12	7	7	8	13	8	8	9	13	9	9	9	8	8
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	1.04%	1.01%	1.04%	1.05%	1.05%	1.00%	0.99%	1.02%	1.01%	0.99%	1.04%	1.00%	0.98%	1.10%	1.07%	1.00%	1.01%	1.00%

Stryker's average Quarter revenue forecast for Mar 24 based on 9 analysts is $5.10B, with a low forecast of $5.10B, and a high forecast of $5.10B. SYK's average Quarter revenue forecast represents a -12.22% decrease compared to the company's last Quarter revenue of $5.82B (Dec 23).

Stryker EBITDA Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	17	15	8	9	13	16	8	9	12	7	7	8	13	8	8	9	13	9	9	9	8	8
EBITDA	-	-	-	-	-	-	-	-	-	-	-	-	$1.26B	$931.00M	$965.00M	$992.00M	$1.44B	$1.05B	$1.03B	$717.00M	$995.00M	$730.00M	$903.00M	$643.00M	$894.00M	$978.00M	$106.00M	$788.00M	$1.13B	$775.00M
Avg Forecast	$1.95B	$1.68B	$1.66B	$1.61B	$1.80B	$1.56B	$1.54B	$1.49B	$1.67B	$1.41B	$1.42B	$752.09M	$1.47B	$1.28B	$1.27B	$683.71M	$1.10B	$1.04B	$1.06B	$621.56M	$1.08B	$985.38M	$967.02M	$662.39M	$1.01B	$795.66M	$605.34M	$718.06M	$958.88M	$835.12M
High Forecast	$1.98B	$1.71B	$1.69B	$1.64B	$1.83B	$1.59B	$1.57B	$1.52B	$1.70B	$1.41B	$1.42B	$902.50M	$1.50B	$1.29B	$1.29B	$820.46M	$1.32B	$1.04B	$1.06B	$745.87M	$1.08B	$985.38M	$967.02M	$794.86M	$1.01B	$795.66M	$605.34M	$861.67M	$958.88M	$835.12M
Low Forecast	$1.91B	$1.65B	$1.63B	$1.58B	$1.77B	$1.53B	$1.51B	$1.45B	$1.64B	$1.41B	$1.42B	$601.67M	$1.44B	$1.26B	$1.24B	$546.97M	$878.82M	$1.04B	$1.06B	$497.25M	$1.08B	$985.38M	$967.02M	$529.91M	$1.01B	$795.66M	$605.34M	$574.45M	$958.88M	$835.12M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.86%	0.73%	0.76%	1.45%	1.31%	1.01%	0.98%	1.15%	0.92%	0.74%	0.93%	0.97%	0.89%	1.23%	0.18%	1.10%	1.18%	0.93%

9 analysts predict SYK's average Quarter EBITDA for Mar 24 to be $752.09M, with a high of $902.50M and a low of $601.67M. This is -40.17% lower than Stryker's previous annual EBITDA (Dec 23) of $1.26B.

Stryker Net Income Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	17	15	8	9	13	16	8	9	12	7	7	8	13	8	8	9	13	9	9	9	8	8
Net Income	-	-	-	-	-	-	-	-	-	-	-	-	$1.14B	$692.00M	$738.00M	$592.00M	$563.00M	$816.00M	$656.00M	$323.00M	$662.00M	$438.00M	$592.00M	$302.00M	$568.00M	$621.00M	$-83.00M	$493.00M	$725.00M	$466.00M
Avg Forecast	$1.80B	$1.36B	$1.35B	$1.23B	$1.63B	$1.24B	$1.23B	$1.10B	$1.49B	$1.07B	$1.08B	$386.82M	$1.26B	$938.83M	$917.98M	$351.66M	$730.88M	$847.46M	$876.44M	$319.69M	$1.05B	$877.36M	$823.78M	$311.11M	$981.27M	$543.01M	$215.45M	$449.24M	$946.35M	$732.83M
High Forecast	$1.85B	$1.39B	$1.38B	$1.26B	$1.67B	$1.27B	$1.26B	$1.22B	$1.51B	$1.07B	$1.08B	$464.19M	$1.29B	$957.76M	$939.32M	$421.99M	$877.05M	$847.46M	$876.44M	$383.62M	$1.05B	$877.36M	$823.78M	$373.33M	$981.27M	$543.01M	$215.45M	$539.09M	$946.35M	$732.83M
Low Forecast	$1.76B	$1.33B	$1.32B	$1.20B	$1.59B	$1.21B	$1.20B	$1.05B	$1.47B	$1.07B	$1.08B	$309.46M	$1.23B	$885.83M	$894.84M	$281.32M	$584.70M	$847.46M	$876.44M	$255.75M	$1.05B	$877.36M	$823.78M	$248.88M	$981.27M	$543.01M	$215.45M	$359.39M	$946.35M	$732.83M
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.91%	0.74%	0.80%	1.68%	0.77%	0.96%	0.75%	1.01%	0.63%	0.50%	0.72%	0.97%	0.58%	1.14%	-0.39%	1.10%	0.77%	0.64%

Stryker's average Quarter net income forecast for Mar 24 is $386.82M, with a range of $309.46M to $464.19M. SYK's average Quarter net income forecast represents a -66.16% decrease compared to the company's last Quarter net income of $1.14B (Dec 23).

Stryker SG&A Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	17	15	8	9	13	16	8	9	12	7	7	8	13	8	8	9	13	9	9	9	8	8
SG&A	-	-	-	-	-	-	-	-	-	-	-	-	$1.94B	$1.70B	$1.71B	$1.78B	$1.75B	$1.46B	$1.54B	$1.71B	$1.75B	$1.60B	$1.50B	$1.57B	$1.56B	$1.24B	$1.23B	$1.33B	$1.38B	$1.29B
Avg Forecast	$2.67B	$2.31B	$2.28B	$2.21B	$2.47B	$2.14B	$2.12B	$2.05B	$2.29B	$1.93B	$1.94B	$2.05B	$2.01B	$1.75B	$1.74B	$1.86B	$1.93B	$1.61B	$1.64B	$1.69B	$1.68B	$1.53B	$1.50B	$1.62B	$1.56B	$1.23B	$937.51M	$1.21B	$1.49B	$1.29B
High Forecast	$2.71B	$2.35B	$2.32B	$2.25B	$2.51B	$2.18B	$2.16B	$2.08B	$2.33B	$1.93B	$1.94B	$2.46B	$2.05B	$1.77B	$1.77B	$2.23B	$2.31B	$1.61B	$1.64B	$2.03B	$1.68B	$1.53B	$1.50B	$1.95B	$1.56B	$1.23B	$937.51M	$1.45B	$1.49B	$1.29B
Low Forecast	$2.62B	$2.26B	$2.24B	$2.17B	$2.42B	$2.10B	$2.08B	$1.99B	$2.25B	$1.93B	$1.94B	$1.64B	$1.98B	$1.73B	$1.70B	$1.49B	$1.54B	$1.61B	$1.64B	$1.35B	$1.68B	$1.53B	$1.50B	$1.30B	$1.56B	$1.23B	$937.51M	$969.56M	$1.49B	$1.29B
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.96%	0.97%	0.98%	0.96%	0.91%	0.90%	0.94%	1.01%	1.04%	1.05%	1.00%	0.97%	1.00%	1.01%	1.31%	1.10%	0.93%	1.00%

Stryker's average Quarter SG&A projection for Mar 24 is $2.05B, based on 9 Wall Street analysts, with a range of $1.64B to $2.46B. The forecast indicates a 5.51% rise compared to SYK last annual SG&A of $1.94B (Dec 23).

Stryker EPS Forecast

	Dec 26	Sep 26	Jun 26	Mar 26	Dec 25	Sep 25	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
# Analysts	6	4	4	6	4	3	7	9	17	15	8	9	13	16	8	9	12	7	7	8	13	8	8	9	13	9	9	9	8	8
EPS	-	-	-	-	-	-	-	-	-	-	-	-	$3.01	$1.82	$1.94	$1.56	$1.48	$2.16	$1.73	$0.86	$1.75	$1.17	$1.57	$0.80	$1.51	$1.66	$-0.22	$1.32	$1.94	$1.24
Avg Forecast	$4.68	$3.53	$3.51	$3.19	$4.24	$3.22	$3.20	$2.85	$3.87	$2.77	$2.79	$2.36	$3.27	$2.43	$2.38	$2.00	$2.84	$2.20	$2.27	$1.95	$2.72	$2.28	$2.14	$1.99	$2.55	$1.41	$0.56	$1.81	$2.46	$1.90
High Forecast	$4.79	$3.61	$3.59	$3.26	$4.34	$3.29	$3.27	$3.17	$3.92	$2.77	$2.79	$2.36	$3.34	$2.48	$2.44	$2.05	$2.90	$2.20	$2.27	$1.95	$2.72	$2.28	$2.14	$1.99	$2.55	$1.41	$0.56	$1.81	$2.46	$1.90
Low Forecast	$4.56	$3.44	$3.42	$3.11	$4.13	$3.14	$3.12	$2.72	$3.81	$2.77	$2.79	$2.36	$3.19	$2.30	$2.32	$1.95	$2.76	$2.20	$2.27	$1.95	$2.72	$2.28	$2.14	$1.99	$2.55	$1.41	$0.56	$1.81	$2.46	$1.90
Surprise %	-	-	-	-	-	-	-	-	-	-	-	-	0.92%	0.75%	0.81%	0.78%	0.52%	0.98%	0.76%	0.44%	0.64%	0.51%	0.73%	0.40%	0.59%	1.18%	-0.39%	0.73%	0.79%	0.65%

According to 9 Wall Street analysts, Stryker's projected average Quarter EPS for Mar 24 is $2.36, with a low estimate of $2.36 and a high estimate of $2.36. This represents a -21.74% decrease compared to SYK previous annual EPS of $3.01 (Dec 23).

Stryker Peer Comparison by Price Target

Ticker	Company	Last Closing Price	Avg Price Target	Upside/Downside	Avg Rating
MDT	Medtronic	$84.11	$107.91	28.30%	Hold
EW	Edwards Lifesciences	$69.54	$88.04	26.60%	Buy
ZBH	Zimmer Biomet	$109.27	$133.78	22.43%	Hold
STE	STERIS	$212.25	$256.67	20.93%	Buy
ABT	Abbott Laboratories	$115.93	$126.45	9.07%	Buy
DXCM	DexCom	$75.24	$81.36	8.13%	Buy
ZIMV	ZimVie	$13.49	$14.50	7.49%	Buy
SNN	Smith & Nephew	$25.21	$27.00	7.10%	Buy
SYK	Stryker	$385.68	$317.96	-17.56%	Buy

SYK Forecast FAQ

Is Stryker a good buy?

Yes, according to 18 Wall Street analysts, Stryker (SYK) is considered a 'Buy'. The rating consensus is based on 0 'Strong Buy' and 15 'Buy' recommendations, accounting for 83.33% of SYK's total ratings.

What is SYK's price target?

Stryker (SYK) average price target is $317.96 with a range of $245 to $420, implying a -17.56% from its last price of $385.68. The data is based on 18 Wall Street analysts who provided a twelve-month price target estimate in the last three months.

Will Stryker stock go up soon?

According to Wall Street analysts' prediction for SYK stock, the company can go down by -17.56% (from the last price of $385.68 to the average price target of $317.96), up by 8.90% based on the highest stock price target, and down by -36.48% based on the lowest stock price target.

Can Stryker stock reach $600?

SYK's average twelve months analyst stock price target of $317.96 does not support the claim that Stryker can reach $600 in the near future.

What is Stryker's current price target trend?

5 Wall Street analysts forecast a $401 price target for Stryker (SYK) this month, up 3.97% from its last price of $385.68. Compared to the last 3 and 12 months, the average price target increased by 1.41% and decreased by -1.03%, respectively.

What are Stryker's analysts' financial forecasts?

Stryker's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $24.4B (high $24.83B, low $23.87B), average EBITDA is $6.4B (high $6.51B, low $6.26B), average net income is $5.21B (high $5.43B, low $5.05B), average SG&A $8.77B (high $8.93B, low $8.58B), and average EPS is $13.5 (high $14.08, low $13.1). SYK's analysts financial forecasts for the fiscal year (Dec 2026) are as follows: average revenue is $26.33B (high $26.8B, low $25.82B), average EBITDA is $6.91B (high $7.03B, low $6.77B), average net income is $5.75B (high $5.88B, low $5.6B), average SG&A $9.47B (high $9.64B, low $9.28B), and average EPS is $14.9 (high $15.25, low $14.53).

Did the SYK's actual financial results beat the analysts' financial forecasts?

Based on Stryker's last annual report (Dec 2022), the company's revenue was $18.45B, beating the average analysts forecast of $18.14B by 1.68%. Apple's EBITDA was $4.24B, beating the average prediction of $3.82B by 11.05%. The company's net income was $2.36B, missing the average estimation of $2.77B by -15.01%. Apple's SG&A was $6.46B, missing the average forecast of $6.87B by -6.03%. Lastly, the company's EPS was $6.23, missing the average prediction of $9.25 by -32.68%. In terms of the last quarterly report (Dec 2023), Stryker's revenue was $5.82B, beating the average analysts' forecast of $5.6B by 3.80%. The company's EBITDA was $1.26B, missing the average prediction of $1.47B by -14.45%. Stryker's net income was $1.14B, missing the average estimation of $1.26B by -9.31%. The company's SG&A was $1.94B, missing the average forecast of $2.01B by -3.63%. Lastly, the company's EPS was $3.01, missing the average prediction of $3.27 by -7.91%